Rajesh Chopra, vice president of translational and early drug development at Celgene Corporation, has joined the board of directors of e-Therapeutics Plc as a non-executive director. A clinician and scientist by training, Dr Chopra leads a group of around 100 people working to integrate drug discovery and clinical development at Celgene sites in the US and Spain. Before joining Celgene, he spent five years at AstraZeneca Plc in the US and the UK. He holds a BSc and an MBBS from University College and Middlesex School of Medicine, University of London and a PhD from the University of London.
Copyright 2012 Evernow Publishing Ltd